2020 Communication Pharmaceutical Manufacturing 
Pharmaceutical Technology
JUNE 19, 2025
Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals. Give your business an edge with our leading industry insights.
pharmaphorum
MARCH 8, 2022
I have been general manager for Merck Healthcare UK & Ireland since 2020. Effectively managing internal politics does not mean you have to be subdued; you must communicate in an effective way that retains your values. Dr Doina Ionescu has been Merck’s General Manager for the UK & Ireland since May 2020.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Proxsys Rx
OCTOBER 6, 2022
340B ESP has added a shameless layer of headaches to 340B programs According to its website , “340B ESP allows 340B covered entities and pharmaceutical manufacturers to work collaboratively to resolve duplicate discounts.” There are many places where communication failures can and do occur.
Putting Patients First Blog
APRIL 7, 2025
By ensuring that any inherent limitations or biases are recognized, addressed, and clearly communicated to clinicians and patients, the FDA can help sustain public trust in AI-driven regulatory processes. These variables, tailored to the intended users, can help identify where improvements are needed to support confident decision-making.
Pharmaceutical Technology
DECEMBER 6, 2022
Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).
Pharmaceutical Technology
MARCH 22, 2023
Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Moreover, US Pharmacopeia issued the first-ever Medicine Supply Map to find and quantify risks in upstream pharmaceutical supply chains across the country. For innovative medicines, this share was 77%.
European Pharmaceutical Review
JULY 21, 2023
What are the top three supply-related challenges facing pharmaceutical manufacturers? This allows for better coordination, communication, and information sharing during times of crisis, enabling quick response and alternative solutions. The facility aims to support vaccination efforts at both national and international levels.
Expert insights. Personalized for you.
Let's personalize your content